Clinical Trial Update: Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating the combination of plasma exchange, rituximab, and steroids for acute exacerbations of idiopathic pulmonary fibrosis, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Plasma exchange
• Rituximab (rituximab)
• steroids

Snippet

Sponsor: Michael Donahoe | Conditions: IPF | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-01-24